Search
banner

Advances in Diagnosis and Treatment of Neuromuscular & Neurodegenerative Disorders: What's Changed in 2016?

New Findings, Updates, and Treatments: Multiple Sclerosis, Parkinson’s Disease & Chameleons, Myasthenia Gravis vs. Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculopathy, Amyotrophic Lateral Sclerosis/ Motor Neuron Disease
Old price: $219.99
$37.00
Product available, you can view or download immediately after payment
Immediate Download after purchase

Information

Faculty:
Susan Fralick-Ball
Duration:
Full Day
Format:
Audio and Video
Copyright:
Oct 18, 2016

Description

New Findings, Updates, and Treatments:

  • Innovative Treatment Regiments for PTs, OTs and SLPs
  • Genomic Markers for Diagnosis and Treatment
  • Medications vs. Hands-On Treatment
  • Symptom Management and Long-Term Care

Multiple Sclerosis, Parkinson’s Disease & Chameleons, Myasthenia Gravis vs. Lambert-Eaton Myasthenic Syndrome, Muscular Dystrophy, Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculopathy, Amyotrophic Lateral Sclerosis/ Motor Neuron Disease

These disorders remain the nation’s leading causes of disability. They are devastating and costly. Due to the aging population, the incidence of these disorders is increasing rapidly. There is a need to provide early diagnosis and apply effective therapies for these disorders. Join expert, Susan Fralick-Ball, PsyD, MSN, CLNC, CH, to learn new strategies for pathophysiologic changes, clinical manifestations, and diagnostic studies for each of these disorders. Gain information on the latest innovative drugs that are geared to slow or stop the disorder progression. Through an engaging presentation style and enlightening case studies, Dr. Fralick-Ball will enhance your knowledge regarding current practice issues. The evidence-based content will improve outcomes for your patients with neuromuscular and neurodegenerative disorders.

Handouts

Outline

Multiple Sclerosis

  • 4 classifications
  • Risk factors: Low Vitamin D, abnormal lipid metabolism
  • Making the diagnosis 1-2-3
    • Neuromyelitis Optica, nystagmus
    • Genomic markers
  • MRI plain and 3-D
  • Treating multiple complications
  • Get Dancing and Get on a Bike exercises for MS
  • Medication updates 2016
  • Case Study

Parkinson’s Disease

  • Degeneration, Decline, and Autonomic Disease
    • A Prion Disease?
  • T-R-A-P symptoms
  • Non-motor complications
  • Biomarkers, LRRK variants
  • Medical treatment
    • Medications
    • Neuroprotection
  • Surgical treatment
    • Palidotomy, Thalamotomy, DBS, Stem cell transplantation
  • New PT/OT/SP guidelines for early engagement
    • Bikes, boxing, Big & Loud programs, forced exercise
    • Electrical stimulation
  • PD chameleons
    • Essential Tremor
    • Progressive supranuclear palsy
    • Corticobasilar degeneration
  • Case Study

Myasthenia Gravis

  • Neuromuscular Junction Disorder
    • Autoimmune
    • T-cell interference at NMJ
  • Edrophonium (Enlon™) Test for Diagnosis
    • MG vs. Lambert-Eaton
  • Short-acting anticholinesterase inhibitors
  • Thymectomy
  • Crisis: Myasthenic vs. Cholinergic
  • Emergent Treatment: Steroids, IVIG, Plasma
  • Exchange
  • Case Study

Muscular Dystrophy

  • Symptoms & causes
  • Complications over time
  • Treatment: Medical and surgical
  • Case Study

Guillain-Barré Syndrome

  • Syndrome of peripheral demyelination
    • Ascending
    • Pure motor
    • Descending
    • Miller-Fisher
  • Early diagnosis, earlier recovery
  • Causes: Viral, bacterial, surgical, vaccines, hyponatremia
  • Medical treatment: The Big 3 (steroids, IVIG, Plasmapheresis)
  • PT/OT/ST/Psych guidelines
  • Case Study

Chronic Inflammatory Demyelinating Polyneuropathy/radiculopathy

  • The elusive diagnosis dilemma
    • Symptoms, testing
  • Medical treatment for the short- and long-term
    • Living with neuropathic pain
    • Medication, spinal/brain stimulation
  • Best PT/OT guidelines
  • Case Study

Amyotrophic Lateral Sclerosis

  • Degeneration of the motor neurons
  • Genetic or generic disease?
    • Rule out everything else
  • Risk factors and neuroprotection
  • Medications help the complications
    • Alternative treatments
    • Stem cell research
  • Palliative considerations

Faculty

Susan Fralick-Ball, Psy.D., MSN, CH Related seminars and products: 5


Dr. Susan Fralick-Ball, PsyD, MSN, CLNC, CH, is a licensed clinical neuropsychologist with an additional 40 years of clinical/educational nursing practice in a wide range of specialties. As a neuropsychologist, she has worked with patients having a vast variety of neurological disorders. Susan was responsible for coordinating all clinical and administrative activities for the stroke program of a nationally renowned neurological-medical rehabilitation hospital where she also developed a stroke support group for patients, family members, and staff. Additionally, she aided patients with neuromuscular and neurodegenerative disorders such as MS, Guillain-Barré, CIDP, Parkinson's, Myasthenia Gravis, ALS, Spinal cord injuries, TBI, head trauma, and dementias. 

As a former member of the Neurocognitive Regional Conference Committee, Susan was instrumental in developing and speaking at conferences to teach medical and health care support staff about neurological challenges and developments. She has also taught neurological nursing and neurophysiology at the graduate level. She has mentored and supervised nurses, social workers, psychologists, and music therapists in the clinical setting. Dr. Fralick-Ball is the founder of the PsychMedEd where she continues to work with patients challenged by the detrimental psychological effects of neurological disorders, is a clinical neuropsychologist for the VistaMed group in the greater Philadelphia area, and a nationally recognized nursing/psychology educator and conference presenter.  She continues to lend social assistance to those with neurological disorders through her charitable organization, With Thy Grace.